{"id":163827,"date":"2022-10-11T02:07:46","date_gmt":"2022-10-11T06:07:46","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/press-release-dupixent-dupilumab-late-breaking-phase-3-data-presented-at-ueg-week-2022-showed-significant-histological-remission-of-eosinophilic\/"},"modified":"2024-08-18T11:46:49","modified_gmt":"2024-08-18T15:46:49","slug":"press-release-dupixent-dupilumab-late-breaking-phase-3-data-presented-at-ueg-week-2022-showed-significant-histological-remission-of-eosinophilic","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/press-release-dupixent-dupilumab-late-breaking-phase-3-data-presented-at-ueg-week-2022-showed-significant-histological-remission-of-eosinophilic.php","title":{"rendered":"Press Release: Dupixent\u00ae (dupilumab) late-breaking Phase 3 data presented at UEG Week 2022 showed significant histological remission of eosinophilic&#8230;"},"content":{"rendered":"<p><![CDATA[Dupixent\u00ae (dupilumab) late-breaking Phase 3 data presented at UEG Week 2022 showed significant histological remission of eosinophilic esophagitis (EoE) in children 1 to 11 years old]]><\/p>\n<p>More here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/10\/11\/2531406\/0\/en\/Press-Release-Dupixent-dupilumab-late-breaking-Phase-3-data-presented-at-UEG-Week-2022-showed-significant-histological-remission-of-eosinophilic-esophagitis-EoE-in-children-1-to-11.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Press Release: Dupixent\u00ae (dupilumab) late-breaking Phase 3 data presented at UEG Week 2022 showed significant histological remission of eosinophilic...\">Press Release: Dupixent\u00ae (dupilumab) late-breaking Phase 3 data presented at UEG Week 2022 showed significant histological remission of eosinophilic...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>More here: Press Release: Dupixent\u00ae (dupilumab) late-breaking Phase 3 data presented at UEG Week 2022 showed significant histological remission of eosinophilic... <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/press-release-dupixent-dupilumab-late-breaking-phase-3-data-presented-at-ueg-week-2022-showed-significant-histological-remission-of-eosinophilic.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-163827","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/163827"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=163827"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/163827\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=163827"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=163827"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=163827"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}